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STUDIES ON THE PATHOGENESIS OF INFLUENZAL PNEUMONITIS.
INTRANASAL VS. INTRAVENOUS INFECTION OF MICEtt
The respiratory epithelium is the only tissue of the adult mouse that is
uniformly susceptible to influenza virus infection. The virus is most effec-
tive when administered intranasally"' although pulmonary lesions can be
produced less regularly by direct intrathoracic inoculation.' Rickard and
Francis'8 were the first to demonstrate virus multiplication and pulmonary
consolidation after parenteral injection of large doses of PR8 influenza
virus, a finding confirmed by Oakley and Warrack" for the WS strain.
The Henles9 noted marked variations in the incidence of pneumonitis after
massive intravenous and intraperitoneal injections of mouse-adapted influ-
enza viruses. Although each of these investigators observed that the mor-
tality rate in parenterally infected mice was lower than in those infected by
the intranasal route, they did not report any basic differences in pulmonary
pathology.
During the course of an investigation on virus distribution in mouse
tissues, it was found that intravenous injection of the highly pathogenic
WS strain of influenza A virus usually produced a nonfatal pneumonitis.
The nature of the infectious process, as reflected in the type of virus multi-
plication and the character of the pulmonary lesions, was deemed to be
sufficiently different from classical intranasal infection to warrant a detailed
description.
MATERIALS AND METHODS
Male Swiss mice (Webster strain) weighing 10-14 gm. were used in all experiments.
The infectivity studies were carried out with the mouse lung-adapted WS strain of
influenza A virus using allantoic fluid preparations of the lOOth-107th consecutive
chick embryo passages. Fluids were obtained from 12-day-old eggs that had been
infected 44 hours previously with 0.1 ml. of a 10' dilution of seed inoculum.
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Mouse inoculation techniques. Intranasal injections were performed under light ether
anesthesia by placing 0.05 ml. of the inoculum on the external nares. In experiments
involving large numbers of mice, an attempt was made to induce the same level of
anesthesia for each animal. Intravenous injections were made in the ventral or dorsal
vein of the tail of unanesthetized mice, the usual volume of the inoculum being 0.1 ml.
Mice were discarded if there was any question of their not having received a full
intranasal or intravenous dose.
Method for obtaining bronchial washings. This method was used to determine the
amount of free virus on the respiratory surface of the tracheo-bronchio-alveolar tree.
Mice were killed with illuminating gas, the anterior skin reflected laterally and the
lungs collapsed by severing the diaphragm just below the xiphoid process. The anterior
thoracic cage was then removed without disturbing the visceral pleura. After exposing
the trachea a 19-gauge needle on the end of a 1.0-ml. tuberculin syringe was inserted
to a point just above the tracheal bifurcation and 0.5 ml. of sterile broth-saline solution
introduced into the lungs. This volume of fluid produced equal expansion of all lobes
without leakage from the pleural surface. The wash fluid was allowed to remain in
the lungs for approximately two minutes before aspiration; each pair of lungs was
washed twice with the same fluid. Approximately 95 per cent of the broth-saline
solution could be recovered after this procedure; the aspirate was usually slightly
cloudy but rarely blood-tinged even in the presence of considerable pulmonary con-
solidation. It is not certain, of course, that the returns were purely from the respira-
tory surface unmixed with interstitial fluid, but Fazekas de St. Groth and Donnelly,'
using a similar technique, have presented evidence for the efficacy of this method.
Infectivity determinations. Lung tissue was emulsified without abrasive in a sufficient
volume of broth-saline solution to make a 10 per cent suspension (wet weight). This
material was then further diluted in 10-fold steps and 0.1-ml. aliquots of each dilution
injected into the allantoic cavities of 4-6 eggs. After 44 hours' incubation the allantoic
fluids were harvested and tested individually for their capacity to agglutinate an equal
volume of one per cent chicken erythrocytes. In addition to the egg infectivity studies,
many of the lung suspensions were tested for hemagglutinin content. This method was
less reliable for estimating virus content due to the presence of nonspecific agglutinins
at low dilutions which tended to obscure the classical patterne' of specific viral hemag-
glutination. In addition, the direct hemagglutination method is not sufficiently sensitive
to detect small quantities of virus since approximately 10'-10 infective doses are
required to produce one hemagglutinating unit.
Egg infectivity and hemagglutinin determinations of bronchial washings were made
in the same manner, using undiluted fluid as the 100 reference point. The results
obtained with this material were eminently more satisfactory than those with whole
lung suspensions. The bronchial washings contained no particulate matter, provided
more uniform suspensions, were invariably free of nonspecific hemagglutinins, and
frequently gave higher egg infectivity and hemagglutinin titers than the lung
suspensions.
Scoring pulmonary consolidation. The method used was essentially that of Ginsberg
and Horsfall7 by which the degree of lung consolidation is estimated by gross inspec-
tion on a scale of 0 to 5+. A percentage rating was then given to each group of simi-
larly treated mice and a mean score (MS5o) calculated on the basis of dilution of
infective material required to produce a 50 per cent consolidation endpoint.
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EXPERIMENTAL RESULTS
Comparative effectiveness ofintranasal and intravenous routes of inoculation
The variations in response of mice to intranasal and intravenous inocula-
tion were determined by comparing the amount of WS virus required to
produce infection, pulmonary consolidation, and death at the 50 per cent
level. Twelve mice were injected by each route with serial 10-fold dilutions
of a single allantoic fluid preparation of WS virus having a hemagglutinin
titer of 1: 4096 and an egg infective titer of 10-9.83. Six mice in each group
were killed in 4 d-ays and their lungs tested individually for the presence of
virus. The incidence of death and the degree of pulmonary consolidation
were noted in the remaining animals over a 10-day period.
TABLE 1. THE AMOUNT OF WS VIRUS REQUIRED TO PRODUCE A 50 PER CENT
INCIDENCE OF INFECTION, PULMONARY CONSOLIDATION, AND DEATH
IN MICE INJECTED INTRANASALLY OR INTRAVENOUSLY
-Log EID50 I.V./I.N. ratios
I.N. I.V. (Antilog)
ID5o* 0.83 6.0 147,000
MSw0t 1.83 9.33 31,700,000
LDoot 2.5 >9.83 .........
* In 4 days.
t In 10 days.
The striking differences in susceptibility by the two routes of inoculation
are shown in Table 1. As noted, the virus was approximately 100,000 times
more infective when administered intranasally. This refractoriness to intra-
venously injected virus was even more apparent when gross pulmonary
lesions and death were considered. In order to produce equivalent degrees
of pulmonary consolidation, 31,000,000 more egg infective doses were
required by the intravenous route than by intranasal injection. A 50 per
cent lethal endpoint was not achieved with the most concentrated intra-
venous inoculum. Two of six mice died in 48 hours after receiving 109.83
EID50 intravenously (undoubtedly due to the toxicity of the preparation9),
but there were no deaths attributable to late pulmonary consolidation.
The fate of the inoculum
It seemed possible that the marked resistance of mice to virus injected
intravenously could be due to failure of a sufficient number of infective
particles to reach the lung. Or, alternatively, the post-inoculation virus
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content of the lung might be high but cells capable of supporting virus
multiplication were relatively inaccessible by this route. These questions
were explored by comparing the amount of "free" virus recovered in the
bronchi and whole lungs at intervals after inoculation. In this manner some
estimate was possible of what proportion of the total virus population of the
lung could traverse the "blood-lung barrier" and find its way to susceptible
cells.
As in the previous experiment, various concentrations of virus were
injected intranasally or intravenously in groups of 18 mice. At arbitrarily
chosen times of 10 minutes and 3 hours after inoculation, when the virus
present represented original inoculum, 6 mice were sacrificed and infectiv-
TABLE 2. WS VIRUS CONTENT OF LUNGS AND BRONCHIAL WASHINGS AT
INTERVALS AFTER INTRANASAL AND INTRAVENOUS INJECTION
Infectivity ratios (-Log EIDs0),
Dose/mouse Whole lung/Bronchi
Route (Log EIDso) 10 min. 3 hr. 24 hr.
I.V. 9.83 6.0/0.75 4.37/2.5 5.5/6.17
7.83 4.5/1.5 3.0/0 4.33/4.5
6.83 4.67/0* 1.33/0 4.25/5.5
5.83 4.25/0 0/0 0.67/0
I.N. 3.83 2.75/2.5 1.23/1.75 7.5/7.0
1.83 0/0 0/0 4.67/3.5
*0 = <100-.
ity determinations made of pooled samples of bronchial washings and lung
suspensions. The procedure was repeated with the remaining 6 mice in each
group 24 hours after inoculation to compare the distribution of actively
multiplying virus.
The results are summarized in Table 2. The proportion of the intra-
venously injected virus recovered from whole lung in 10 minutes varied
with the infecting dose, ranging from 2.6 per cent of the most dilute inocu-
lum to 0.01 per cent of the most concentrated. By the 3d hour after intra-
venous injection a considerable decline in the infective virus content of
whole lung was noted at each dose level. Relatively few infective particles
were found in bronchial washings at 10 minutes and 3 hours and only in the
most heavily exposed mice, representing but a small fraction of the total
lung virus. In the animals that received 106.83 EID60, no virus could be
demonstrated in bronchial washings, but its presence there was attested to
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by the appearance of bronchial virus in moderately high concentration at
24 hours. Whereas the post-inoculation samples showed a preponderance of
virus located extrabronchially, when multiplication ensued, the bronchial
titers exceeded those of whole lung. Undoubtedly, the presence of small
amounts of bronchial virus could not be detected due to the virus-binding
capacity of the cells. This is most clearly demonstrated by intranasal inocu-
lation which resulted in rapid absorption of virus by respiratory epithelium
leaving less than 10 per cent of the inoculum free in the bronchi after 10
minutes. As opposed to intravenous injection, the whole lung/bronchial
ratios of intranasally administered virus were about equal.
There were no significant differences in the recovery rates of intra-
venously injected virus when the volume of the inoculum was increased to
as much as two ml.
It would appear, therefore, that the relative innocuousness of intra-
venously injected virus is due, at least in part, to its inability to reach
susceptible cells in adequate concentration to initiate infection.
Virus growth curves
The interrelationship of pathogenicity and multiplication rate of influenza
viruses has been stressed by many investigators. Different strains vary in
their capacity to produce transmissible pneumonitis after intranasal injec-
tion depending upon their multiplication potentials which, in turn, are
related to their degree of adaptation.2" Rapidly proliferating strains cause
fatal pneumonitis with inocula of low infectivity, whereas avirulent, un-
adapted strains grow poorly and do not produce pulmonary consolidation
unless massive doses are injected.'9 Multiplication of adapted strains may
also be limited with very dilute inocula, in which case the onset of pul-
monary consolidation is correspondingly delayed.' In the last analysis,
probably the most important factor in pathogenicity is the total amount of
virus that the respiratory epithelium is exposed to at any one time, regard-
less of whether this be from newly formed virus or weakly infective inocu-
lated virus. This has been most clearly demonstrated by Ginsberg' who
found that in vaccinated mice immunity could be overcome and extensive
pneumonitis produced with massive intranasal inoculations, in spite of the
absence of a detectable cycle of virus replication.
An example of the influence of the infecting dose on the multiplication
rate of intranasally injected WS virus is shown in Figure 1. When the
inoculum contained 103.83 EID50, the maximum lung and bronchial concen-
trations of infective virus were achieved within 24 hours and all the mice
died in 5 to 7 days with complete pulmonary consolidation. On the other
602
Vol. 28, June 1956Pathogenesis of influenzal pneumonitis I WAGNER
hand, intranasal inoculation of 101.83 EID50 resulted in a slower increase of
virus, generally lower titers late in the course of infection, and an over-all
incidence of only 50 per cent lung lesions. Also noteworthy is the fact that
the bronchial titers frequently exceeded the total lung titers in the same
mice, indicating that a considerable amount of virus was "free" in the
bronchial secretions and that the cells were "saturated."
Returning for a moment to Table 1, it can be seen that a more dilute
intranasal inoculum (10083 EID50) retained its infectivity but completely
lost its pathogenicity. By the intravenous route, on the other hand, greater
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FIG. 1. FIG. 2.
FIG. 1. The relation of multiplication potential to dose of intranasally administered
WS virus.
FIG. 2. WS virus growth curves after intranasal and intravenous inoculation.
than a 1000-fold increase in the IDr5 level was required to produce 50 per
cent consolidation and an LD5o concentration was unattainable. These data
suggested, that, regardless of the amount of virus reaching the respiratory
epithelium after intravenous injection, it was severely limited in its
proliferative potential, both as to rate and extent of multiplication.
Support for this hypothesis was obtained by examining in detail the virus
growth curves after intravenous injection of various concentrations of WS
virus. As seen in Table 3, there was little difference in production of infec-
tive virus over a wide intravenous dose range and, most strikingly, the
titers rarely exceeded 106s5 EID50 even with the heaviest inoculum. Also,
there was no evidence of significant virus multiplication outside of the
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respiratory epithelium for, as was the case with intranasal infection, the
virus content of the bronchial washings was usually greater than that of
whole lung in the same mice. This, incidentally, would appear to be pre-
sumptive evidence that bronchial epithelial cells are infected by intravenous
as well as intranasal injection.
Bronchial growth curves are presented in Figure 2 to show more clearly
the comparative response of mice to a small intranasal and a large intra-
venous dose of WS virus. It is apparent that the mechanism of infection is
quite different, not only in regard to the invasiveness of virus by the two
routes, but also in the essential dissimilarity of virus growth.
TABLE 3. DAILY WHOLE LUNG/BRONCHIAL WS Vmus TITERS
(-LOG EID60) AFTER INTRAVENOUS INJECTION
Log Days after injection
I.V. dose 1 2 3 4 5 7
9.83 5.5/6.17 5.5/6.5 6.0/6.29 6.25/7.0 5.5/6.4 4.75/4.5
7.83 4.33/4.5 5.5/5.5 5.78/6.5 4.75/5.5 ...... 4.33/5.5
6.83 4.25/5.5 4.33/4.25 4.5/5.5 5.5/5.33
5.83 0.67/0* 0/0 4.33/5.25 3.76/4.33
4.83 0/0 0/0 0/0 0/0
*0 = <100.5.
Hemagglutinin-infectizity ratios
One possibility that required consideration was that intravenous infection
results in an entirely different mode of virus replication involving the pro-
duction of noninfectious particles, the so-called "incomplete virus" of von
Magnus.' Such a cycle of influenza virus multiplication has been demon-
strated in insusceptible tissues like mouse brain after direct inoculation of
very large doses of the PR8 strain.' Since mouse lung also exhibited a
relatively poor response to massive parenteral doses of virus, further
studies were carried out to determine whether noninfectious hemagglutinins
appeared at any stage after intravenous infection.
An allantoic fluid preparation of WS virus was used that contained
approximately 105-5 EID5O for each unit of hemagglutinin, a ratio which is
in the usually accepted range for highly infective influenza virus. This
material was injected undiluted into 24 mice by the intravenous route and
individual assays made of the hemagglutinin and egg infective titers of both
the bronchial washings and whole lung suspensions of 4 mice at daily inter-
vals thereafter. Hemagglutination titrations of all specimens were carried
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out in citrate-saline solution after treatment with receptor-destroying
enzyme in order to inactivate virus inhibitors.
As shown in Table 4, the expected ratios of hemagglutinating to infective
virus were obtained throughout the 6-day experimental period. It appears
reasonable to assume, therefore, that only fully infective particles are being
produced in response to intravenous infection. Similar ratios were also
obtained after intranasal injection. Furthermore, these experiments provide
additional evidence that the differences in the virus growth curves after
intravenous infection are not due to significant extrabronchial multiplication
of either infective or "incomplete" virus.
TABLE 4. HEMAGGLUTININ/INFECTIVITY RATIOS AFTER INTRAVENOUS
INJECTION OF UNDILUTED WS VIRUS
Day
1 2 3 4 6
Whole lung 0/10.5 0/104./ 2/10" 0/10". 3.2/105
Bronchi 0/10.80 0/10'X 2/10' 7 6.4/105-8' 8/l1O-
The values are the reciprocal geometric mean.
HA/EID5o titers of 4 mice. 0 = <2.
Although the hemagglutinin titer may provide a more accurate means for
following the course of well-established infections, it is quite apparent that
this method is insufficiently sensitive to detect the presence of low grade
infections. Nevertheless, most of the detailed studies of influenza virus
infection of mouse lung that have been done in the recent past have used
viral hemagglutinins as the index of infection. For example, in the exhaust-
ive series of experiments reported by Fazekas de St. Groth and Donnelly3
there was no hemagglutinin detectable in the lung after large intraperi-
toneal or subcutaneous injections of the Melbourne A strain, leading these
authors to conclude that "active virus given by extrarespiratory routes is
as incapable of causing infection as inactivated vaccines given by any route."
Serial intravenous passage
In their studies on influenza virus toxicity the Henlese found considera-
able variation in the frequency with which late pulmonary consolidation
could be produced after parenteral injection of mouse-adapted strains.
Since it was conceivable that these strain differences might have been
related to degree of adaptation, an attempt was made to augment the intra-
venous pathogenicity of WS virus by serial passage in the hope that a more
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virulent form would arise. Presumably, this might occur by mutation or
selection of a variant with greater invasive and proliferative potential by
the intravenous route of inoculation. The series was initiated by injecting
10 mice intravenously with 0.1 ml. of undiluted WS allantoic fluid. After
4 days 5 of the animals were sacrificed and their bronchial washings col-
lected, titered, and pooled. This material was then immediately injected
intravenously into 10 new mice and the cycle repeated thereafter at 4-day
intervals. The incidence of death and the degree of pulmonary consolidation
over a 10-day period were recorded in the remaining 5 mice of each group.
No deaths occurred and only minimal pulmonary consolidation was noted
during the first 9 passages. Deaths were occasionally encountered in sub-
sequent passages, but the mortality rate did not increase consistently. The
degree of pulmonary consolidation was also more marked in the later
passages but was almost always sporadic and rarely exceeded an over-all
score of 50 per cent, occasionally reverting to less than 10 per cent for no
apparent reason. Successive transfer did not result in increasing infectivity
and hemagglutinin titers of the bronchial washings nor was there any defi-
nite correlation between virus content of the lungs and extent of pneumo-
nitis. The experiment was terminated at the 28th consecutive intravenous
passage at which time the virus was somewhat more pathogenic but
exhibited no alteration in its multiplication potential in mouse lung by
either the intravenous or intranasal route.
The Taylor phenomenon
As previously mentioned, an important limiting factor in the intranasal
pathogenicity of any virus strain is the dose of the inoculum. Small doses of
virus undergo a reproductive cycle characterized by a slower rate of
increase and invariably lower titers than do lethal inocula. However, at 48
hours after infection the lungs of surviving mice may contain more than
1,000,000 infective virus particles. The most succinct expression of this
paradox is contained in a paper by Taylor :' ". . . the lungs of one of these
mice contained sufficient virus to infect fatally 76,000 normal mice, yet the
mouse whose lungs harbored this enormous amount of virus in some way
managed to master the infection and survive. Nor did the virus further
increase after it reached a maximum at 48 hours following inoculation."
Somewhat by accident Taylor'2 discovered that this phenomenon is related
to mechanical bronchogenic dissemination and the capacity of the host to
localize the sublethal infection. Simple intranasal instillation of sterile
water, saline solution, broth, or 10 per cent normal serum four days after
a sublethal inoculation "produced a sharp rise in the virus content of the
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lungs followed by death in 3 to 8 days." Pathological lesions in these mice
were identical to those seen in animals receiving a lethal intranasal injection.
Similar observations had also been made by Straub.'8
The Taylor phenomenon afforded an additional means of comparing
sublethal intranasal and intravenous pulmonary infections. A group of 20
mice was injected intranasally with 101.83 EID50 of WS virus and an equal
number with 107.83 EID50 intravenously. These doses of virus by them-
selves did not cause death and produced roughly equivalent bronchial titers.
Four days after injection each of these 40 mice was given 0.05 ml. of sterile
broth-saline solution intranasally. All 20 of the mice originally infected by
the intranasal route died with complete pulmonary consolidation between 2
and 8 days after the second inoculation. On the other hand, only 5 of the
20 intravenously infected mice succumbed from 3 to 7 days after intranasal
instillation of broth-saline solution. It would appear, therefore, that intra-
venously administered virus is in a less advantageous position to be
disseminated by the bronchogenic route.
Interfering action of intravenously administered virus
Rickard and Francis1" have presented evidence of a rapidly developing
resistance to intranasal PR8 virus infection in mice previously inoculated
intraperitoneally with live homologous virus. This protective effect was
maximal when the interval to challenge was two days, during a time when
circulating antibody could not be detected. Oakley and Warrack'2 were
unable to duplicate these results with either PR8 or WS virus but enter-
tained the possibility that their preliminary intraperitoneal injections were
too small to confer resistance.
The results of the following experiment support the findings of Rickard
and Francis.' Four groups of 20 mice were injected with normal allantoic
fluid (NAF) or sublethal doses of WS virus, as follows: Group I-NAF
0.05 ml. intranasally; Group II-NAF 0.1 ml intravenously; Group III-
101.83 EID50 of WS virus intranasally; and Group IV-107-83 EID50 of
WS virus intravenously. Two days after these preliminary injections all 80
animals were challenged with 50 LD50 of WS virus by the intranasal route.
As shown in Table 5 all but 1 of the 60 mice in Groups I, II, and III died
with complete pulmonary consolidation. On the other hand, 60 per cent of
the mice that had received a preliminary intravenous virus inoculation
survived the challenge injection, in spite of the fact that extensive pulmon-
ary consolidation was noted at the end of the 10-day experimental period.
It would appear, therefore, that the interfering action of intravenously
injected virus represents an additional distinguishing feature from classical
intranasal infection.
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Pathology
Credit for the earliest and most concise description of the morphology
and pathogenesis of murine influenza virus pneumonitis belongs to
Straub."7
' He states that following intranasal infection "the first localisa-
tion of this process (gross lesion) is often found near the hilum of one or
more lobes; later on entire lobes or almost the whole of both lungs except
the edges may be affected." The gross morphological changes were not
considered to be peculiar to influenza virus infection but many of the micro-
scopic lesions appeared to be quite specific reactions to this organism. His
most pertinent observation was that experimental influenza infection in the
mouse is primarily a disease of bronchial and bronchiolar epithelium.
TABLE 5. RESISTANCE TO INTRANASAL CHALLENGE OF LD60 OF WS
VIRUS Two DAYS AFTER PRELIMINARY INJECTION
Interfering 'ivrus
Group Route Dose (EID5o) Mortality % Lung lesions
I I.N. 0 (NAF) 20/20 100
II I.V. 0 (NAF) 19/20 99
III I.N. 101U83 20/20 100
IV I.V. 10X- 8/20 80
Sequentially, there is destruction of epithelial cells which desquamate in 2
or 3 days followed by replacement with a fibrinoid material poor in inflam-
matory cells. Even the terminal bronchioles, which in the mouse are lined
with cuboidal epithelium to their junction with alveolar sacs, are involved
in this process but the alveolar cells themselves are spared. Parenthetically,
a true hyaline membrane has not been noted.10 Associated with these
changes are peribronchial edema, collapse of alveolar segments with com-
pensatory emphysema in uninvolved areas, interstitial edema and hemor-
rhage, and varying degrees of infiltration with polymorphonuclear leuko-
cytes. The final gross appearance of plum-colored consolidation is due,
therefore, to atelectasis, the extent of the lesions being dependent upon the
degree of bronchiolar involvement. Death ensues only when most of the
pulmonary parenchyma is involved, varying with the virus dose from 3 to
as long as 10 days after intranasal injection. Somewhat more detailed
descriptions of certain aspects of the pathogenicity of this disease, particu-
larly the early cytoplasmic and ciliary changes in epithelial cells, are
contained in the reports of Loosli10 and Harford and Hamlin.8
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Of the greatest interest, perhaps, is Straub's observation that the repara-
tive process may begin as early as the 5th day even in fatal infections.
Proliferation of new bronchial and bronchiolar epithelium is seen at this
time which is low cuboidal or squamous in appearance, closely resembling
the lesions described by Winternitz et al.' in pandemic human influenza.
Mice surviving the infection may show an extraordinary picture several
weeks after inoculation. The involved portions of the lung contain nests of
squamous epithelial cells with many mitotic figures, not only in the
bronchioles but also proliferating downward to fill the alveoli. However,
this metaplastic squamous epithelium does not invade interalveolar spaces,
and the alveolar septa themselves appear to be well preserved.
In the present studies the pathological changes in the lungs following
intranasal injection of WS virus were essentially similar to those described
above. Macroscopically, plum-colored consolidation was noted in the peri-
hilar areas in 2 to 4 days, depending on the virus concentration of the
inoculum. Mice killed thereafter usually showed more extensive lesions
spreading toward the periphery but even the lungs of those mice dead of
infection usually exhibited a narrow rim of uninvolved lung tissue. The
early microscopic lesions in intranasally injected mice were those of bron-
chitis with progressive desquamation of epithelium, accompanied by peri-
bronchial edema and more extensive peribronchitis and intraluminal
exudate than described by Straub'7 and Loosli.'0 This process, particularly
with small intranasal doses of virus, began in the large bronchi (Fig. 3)
and gradually spread to involve the bronchioles. Replacement of columnar
epithelium by squamous or low cuboidal cells was noted as early as the 4th
day in the large bronchi (Fig. 4) and 1 to 3 days later in the bronchioles.
In marked contrast, the gross pathological findings in intravenously
infected mice were characterized by peripheral, frequently wedge-shaped
pulmonary lesions with hilar sparing. These focal areas of plum-colored
consolidation could be found as early as 3 days after infection and were
most extensive by the 4th or 5th day. The lesions usually remained localized
and ordinarily did not progress to involve the entire lung as was the case
with intranasal infection. Most frequently affected were the right middle
lobe, the apical segment of the left lung, and the subcardiac lobe of the
right lung, in that order. The earliest microscopic lesions in intravenously
infected mice occurred in the small and medium-sized blood vessels of the
lungs, both arteries and veins. Extensive perivascular infiltration with poly-
morphonuclear and mononuclear leukocytes was noted 2 to 3 days after
injection, remaining stationary with little progression or resolution for at
least several weeks (Fig. 5). Only rarely were inflammatory cells seen
invading blood vells walls and there was no destruction or proliferation of
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vascular endothelium. Thromboses were uncommon. Destruction of respira-
tory epithelium was noted by the 3d or 4th day after intravenous infection,
usually focal in distribution and limited to the terminal bronchioles. Unlike
intranasal infection the larger bronchioles and bronchi were never involved
and the degree of peribronchiolar inflammation was minimal. Consolidation,
hemorrhage, edema, and collapse of alveoli occurred in patchy segments,
generally at the periphery of the lung and not unusually involving the
visceral pleura. Straw-colored pleural effusions were occasionally seen with
intravenous but not intranasal infections.
Squamous metaplasia of the bronchiolar epithelium appeared on the4th or
5th day after intravenous infection, becoming increasingly more prominent
thereafter, and was far out of proportion to the rather minimal degree of
bronchiolar destruction that preceded it. The lungs of mice killed two weeks
after intravenous infection presented a striking picture (Fig. 6). The peri-
arteritis had not subsided and squamous epithelial cells with numerous
mitotic figures filled nests of alveoli. By the 23d day the extent of prolifera-
tive epithelialization took on an appearance suggestive of bronchogenic
carcinoma of the squamous cell type, but closer examination revealed that
the interalveolar spaces were not invaded and the basic architecture of the
lung was preserved. There was no desmoplastic reaction in the epithelial
cell masses and the degree of interstitial fibrosis was minimal. Very little
resolution of these lesions was noted as long as three months after infection.
On the basis of the superficial resemblance of these epithelial changes
to neoplasia'7" an attempt was made to transplant lung tissue of intra-
venously infected mice to the subcutaneous space of homologous hosts.
Many of the homografts survived for several weeks but did not exhibit true
epithelial proliferation and could not be retransplanted.
The gross and microscopic pathological changes in the lungs of the
intravenous serial passage mice were similar to those described above but
were generally more extensive. Infected allantoic fluid diluted beyond
103 or normal allantoic fluid injected intravenously produced no vascular
or bronchiolar lesions.
The lungs of mice that survived a challenge intranasal injection of WS
virus given two days after an intravenous interfering dose showed the
histological effects of intranasal infection plus the perivasculitis of intra-
venous infection. Grossly and microscopically the consolidative process ten
days after intranasal challenge was confined to the hilar and peribronchial
areas, almost as if the centrifugal spread of the lesions had been arrested
at the terminal bronchioles.
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Marked inflammatory response
in a major bronchus four days
after intranasal inoculation of
1018' EID50 of WS virus.
Hematoxylin-eosin, x90.
FIG. 4. Intranasal infection.
Higher power (x410) view of
the wall of the bronchus in
Figure 3 showing the thickened
cuboidal metaplastic epithelium.
Note the lack of perivasculitis
of the adjacent arteriole.FIG. 5. Intravenious infection.
Marked perivasculitis, well -
preserved columnar bronchial
epithelium and early squamous
metaplasia six days after infec-
tion. The visceral pleura is also
infiltrated with inflammatory
cells. Hematoxylin-eosin, x130.
FIG. 6. In1traven1ous in1fectioIn.
Masses of squamous epithelial
cells filling nests of alveoli in
the lung of a mouse that sur-
vived 14 days. Note the fairly
well-preserved bronchial epithel-
ium and residual perivasculitis.
Hematoxylini-eosini, x130.Pathogenesis of influenzal pneumonitis I WAGNER
DISCUSSION
Regardless ofwhether virus is administered intranasally or intravenously,
the pathogenesis of influenzal pneumonitis is clearly related to bronchiolitis.
However, the rate of virus multiplication and the severity of the disease
depend, to a large extent, on the route and virus concentration of the
inoculum. Thus, the response to intranasal infection may take three forms
depending on the degree of exposure. With large infective doses the bronchi
and bronchioles are probably involved simultaneously, the virus multiplying
at all sites of primary infection and producing maximum titers within 24
hours. This fulminating infection is accompanied by generalized, uniform
destruction of respiratory epithelium and early atelectasis, consolidation,
and death. An alternative course may be seen with smaller doses of virus
in which the infection is probably confined at first to the upper respiratory
tract and major bronchi resulting in a generally slower rate of virus pro-
liferation. Due to involvement initially of fewer cells, maximum titers are
not obtained until 48 hours after injection and the occurrence of lung
lesions and death is correspondingly delayed. Thirdly, sublethal doses
produce relatively few new infective particles, presumably because the
infectious process is localized to the major bronchi; the majority of bronchi-
oles are spared, the incidence of atelectatic and pneumonitic lesions is low,
and the host, therefore, survives. It is of interest that this capacity to resist
a low-grade infection is largely a matter of lessened mechanical dissemina-
tion of virus, since simple intranasal instillation of bland fluids can convert
the benign course to a fulminating pneumonitis. Notwithstanding these
differences in dose response, influenzal pneumonitis produced by intranasal
injection is essentially a descending bronchogenic infection.
In contrast, infection by the intravenous route appears to be primarily
a focal disease of terminal bronchioles. By and large the virus has no way
of ascending the bronchial tree and in only a limited number of animals can
disseminated infection be produced by intranasal instillation of sterile broth.
Since the infectious process is generally confined to the bronchiolar epi-
thelium, the resulting virus titers are lower than after intranasal infections,
rarely attaining the critical levels of a lethal infection. Although severely
limited, the multiplication potential of the virus and the degree of pulmonary
consolidation depend to some extent on the number of infective particles
that reach susceptible cells by the intravenous route which, in turn, is a
function of dose of inoculum. Unlike intranasal infection, the range be-
tween infective and pathogenetic doses of intravenously injected virus is
extremely wide.
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One possible explanation of the limited susceptibility of lung tissue to
intravenous infection would be that virus replication takes place on the
extrarespiratory surface of the capillary-alveolar membrane. An analogy to
such a situation can be found in the differential susceptibility of the two
sides of the chorio-allantoic membrane of the chick embryo. Fulton and
Isaacs5 clearly demonstrated that the chorionic surface is capable of sup-
porting only a single cycle of influenza virus multiplication and the amount
of antigen produced in these cells is dependent on the infecting dose.
Significantly, they also found that virus did not penetrate to the susceptible
allantoic cells. Of interest also are the findings of Burnet and Fraser2 that
certain strains of virus inoculated intravenously or onto the chorionic sur-
face of the chick embryo chorio-allantois are disseminated to the brain,
resulting in a hemorrhagic encephalitis. Previous inoculation of homologous
virus by the allantoic route interfered with the development of cerebral
hemorrhages, and the embryos survived. These authors suggested that virus
multiplication and interference take place in the capillary endothelial cells
of the brain. However, the evidence in the present studies appears to be
fairly conclusive that multiplication of intravenously administered virus is
confined to the bronchiolar epithelial cells of the mouse. Except for the
immediate post-inoculation period the virus content of bronchial washings
always equalled or exceeded that of whole lung, indicating that little if any
infective virus remained in the interstitium or capillaries. In addition, the
pathologic lesions were those of bronchiolitis rather than interstitial
pneumonia, and perivasculitis without endothelial involvement.
Assuming, therefore, that only the respiratory epithelium of the lung can
serve as substrate for influenza virus multiplication, there appear to be
three possible routes by which the virus can cross the "barrier" from blood
stream to terminal bronchiolar cells. The first is that rupture of submucosal
capillaries may spill virus into the bronchial tree. This explanation seems
least likely because large volumes of inocula, up to two ml. intravenously,
did not enhance pulmonary infectivity, and no extravasation of blood was
seen in sections taken immediately after injection. Of greater likelihood is
that small blood vessels are permeable to small quantities of virus adherent
to their walls. This mode of penetration would be more consistent with the
invariable pathological finding of perivasculitis. Having found its way into
the interstitial tissues the virus may then invade bronchiolar epithelium by
the "back door," that is, the extrarespiratory surface of the cells. An equally
tenable explanation, however, would be that virus diffuses across the
capillary-alveolar membrane with reflux upward to infect adjacent epithelial
cells at their respiratory surface. This last hypothesis would perhaps best
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explain the primary infection of terminal bronchioles and the sparing of
larger branches.
SUMMARY
The pathogenesis of murine influenzal pneumonitis was studied by
comparing the host response to intranasal and intravenous infections with
the mouse-adapted WS strain of influenza A virus. Striking differences
were found in infectivity, pulmonary consolidation, and death by the two
routes of inoculation, as well as post-inoculation distribution of virus in
lungs and bronchi, virus multiplication potentials, capacity of the host to
localize low-grade infections, and interference phenomenon. The primary
pathological findings in either type of infection were early destruction of
respiratory epithelium and subsequent metaplastic regeneration. However,
the distribution of the lung lesions was quite different. After intranasal
infection the major air passages were involved initially, progressing to
extensive bronchitis, atalectasis, diffuse pulmonary consolidation, and
death; whereas, intravenous infection was essentially a benign, focal disease
of terminal bronchioles. It is concluded that the severity of the pneumonitic
process is a function of the extent to which the total mass of respiratory
epithelium is involved, which is, in turn, related to mechanical bronchogenic
dissemination of virus.
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